Clinical trial / 2016
Distal, but not proximal, colonic acetate infusions increased fasting fat oxidation and PYY in overweight or obese men.
Six overweight/obese men underwent two experimental periods with endoscopically placed catheters for distal and proximal colonic infusions of sodium acetate (100 or 180 mmol/l) or placebo across fasting and postprandial conditions. Distal colonic 180 mmol/l acetate infusions significantly increased fasting fat oxidation (1.78±0.28 vs. -0.78±0.89 g fat 2 h-1, P=0.015), fasting PYY (P=0.01), and postprandial glucose and insulin levels (P<0.05) compared to placebo. Distal 100 mmol/l acetate tended to decrease fasting TNF-α (P=0.067). In contrast, proximal colonic acetate infusions had no observed effects on substrate metabolism, circulating hormones, or inflammatory markers.
- Study type
- Randomized, double-blind crossover trial
- Who was studied
- 6 overweight/obese men (BMI 25-35 kg/m2)
- What was measured
- Fat oxidation, energy expenditure, circulating hormones, and inflammatory markers
THE PAPER
Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men.
van der Beek CM, Canfora EE, Lenaerts K, Troost FJ, Damink SWMO, Holst JJ, Masclee AAM, Dejong CHC, Blaak EE. Clin Sci (Lond), 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.